Assenagon Asset Management
ELV icon

Assenagon Asset Management’s Elevance Health ELV Stock Holding History

Assenagon Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116M Buy
299,374
+184,595
+161% +$68.5M 0.14% 120
2026
Q1 		$33.6M Sell
114,779
-414,729
-78% -$136M 0.05% 258
2025
Q4 		$186M Buy
529,508
+76,970
+17% +$26M 0.26% 64
2025
Q3 		$146M Buy
452,538
+72,097
+19% +$22.4M 0.2% 94
2025
Q2 		$148M Buy
380,441
+266,631
+234% +$107M 0.22% 92
2025
Q1 		$49.5M Sell
113,810
-117,842
-51% -$47.3M 0.08% 208
2024
Q4 		$85.5M Sell
231,652
-28,447
-11% -$11.9M 0.14% 135
2024
Q3 		$135M Buy
260,099
+228,256
+717% +$122M 0.25% 71
2024
Q2 		$17.3M Sell
31,843
-193,903
-86% -$102M 0.04% 320
2024
Q1 		$117M Sell
225,746
-85,797
-28% -$42.7M 0.28% 66
2023
Q4 		$147M Sell
311,543
-55,290
-15% -$25.6M 0.39% 45
2023
Q3 		$160M Buy
366,833
+249,533
+213% +$113M 0.49% 30
2023
Q2 		$52.1M Buy
117,300
+36,646
+45% +$16.9M 0.18% 106
2023
Q1 		$37.1M Sell
80,654
-115,833
-59% -$55.1M 0.13% 139
2022
Q4 		$101M Buy
196,487
+51,411
+35% +$26.1M 0.36% 53
2022
Q3 		$65.9M Buy
145,076
+136,930
+1,681% +$65.5M 0.25% 88
2022
Q2 		$3.93M Sell
8,146
-85,188
-91% -$42.1M 0.01% 616
2022
Q1 		$45.8M Buy
93,334
+86,191
+1,207% +$39.4M 0.13% 137
2021
Q4 		$3.31M Buy
7,143
+2,403
+51% +$1.01M 0.01% 636
2021
Q3 		$1.77M Sell
4,740
-76,623
-94% -$29.1M 0.01% 741
2021
Q2 		$31.1M Sell
81,363
-14,884
-15% -$5.69M 0.11% 173
2021
Q1 		$34.5M Buy
96,247
+65,149
+209% +$21M 0.14% 128
2020
Q4 		$9.98M Buy
31,098
+14,165
+84% +$4.35M 0.04% 250
2020
Q3 		$4.55M Sell
16,933
-124,325
-88% -$33.5M 0.03% 350
2020
Q2 		$37.1M Sell
141,258
-128,049
-48% -$34.2M 0.24% 74
2020
Q1 		$61.1M Buy
269,307
+257,564
+2,193% +$70.2M 0.49% 49
2019
Q4 		$3.55M Sell
11,743
-211,744
-95% -$58.3M 0.02% 288
2019
Q3 		$53.7M Buy
223,487
+112,442
+101% +$30.8M 0.36% 60
2019
Q2 		$31.3M Buy
111,045
+22,230
+25% +$6.07M 0.24% 78
2019
Q1 		$25.5M Buy
88,815
+74,066
+502% +$21.4M 0.24% 85
2018
Q4 		$3.87M Buy
+14,749
New +$4.06M 0.04% 293
2018
Q3 		– Sell
-15,957
Closed -$3.8M – 782
2018
Q2 		$3.8M Buy
15,957
+12,648
+382% +$2.93M 0.04% 237
2018
Q1 		$727K Sell
3,309
-155,385
-98% -$36.5M 0.01% 437
2017
Q4 		$35.7M Sell
158,694
-377,213
-70% -$80.3M 0.37% 61
2017
Q3 		$102M Buy
+535,907
New +$102M 0.94% 27

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Assenagon Asset Management's ELV Position: Q2 2026 in Review

Assenagon Asset Management increased its Elevance Health (ELV) stake by 161% in Q2 2026, buying an estimated $68.5M and bringing the position to 299,374 shares worth $116M. The position accounts for 0.14% of the portfolio, ranked #120.

Assenagon Asset Management first reported a position in ELV in Q3 2017 and has held it in 35 quarters since. The position peaked at $186M in Q4 2025. 339 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Assenagon Asset Management held 299,374 shares of Elevance Health worth $116M as of Q2 2026.
  • Assenagon Asset Management bought 184,595 Elevance Health shares in Q2 2026, an estimated $68.5M.
  • Elevance Health made up 0.14% of Assenagon Asset Management's portfolio in Q2 2026, its #120 holding.
  • Assenagon Asset Management first reported a position in Elevance Health in Q3 2017 and has held it in 35 quarters since.
  • Assenagon Asset Management's Elevance Health position peaked at $186M in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.